ArticleFundamental research2025
Deep learning-assisted terahertz intelligent detection and identification of cancer tissue.
Article in Fundamental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advances in optical and electrochemical aptasensors for tumor biomarker alpha-fetoprotein.Mikrochimica acta · 2026Review
- The value of terahertz three-dimensional tomography for the differential diagnosis of tumor tissue and normal tissue in lung cancer nude mice.Frontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer, as one of the most notorious health diseases, represents the main reason attributed to millions of worldwide deaths each year. Timely detection and accurate diagnosis are thus vital to cancer prevention and timely therapy. Traditional cancer prescreening is not only cumbersome but also heavily reliant on sufficient expert knowledge, which inevitably increases the complexity of cancer diagnosis and limits early cancer diagnosis. To overcome this problem, recent terahertz (THz) technology, as an unconventional bio-friendly detection approach, has emerged with great potential in human disease diagnosis due to its non-ionic and high-resolution features. By combining the THz detection technique and artificial intelligence technique, here we propose a dense and efficient channel attention network (DECANet) framework-based THz diagnosis system for cancer prescreening. The cancer identification and diagnosis process are transformed into one end-to-end classification process of THz signals reflected from cancer tissue. The biosamples of breast and skin cancer tissue are characterized to validate the effectiveness and applicability of the proposed approach. Our quantified results indicate that our proposed THz diagnosis framework has promising feature extraction capability for abnormal cancerous tissue and provides an effective complement tool to assist the healthcare cancer diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.